We use cookies on our site to track usage and preferences. Learn more

Biofidelity Announces Formation of Scientific Advisory Board

  • Date 2 Aug 2021

Biofidelity Ltd, the cancer diagnostics company, today announces the members of its newly-formed Scientific Advisory Board (SAB) with the appointments of leaders from the clinical, pharmaceutical and patient advocacy fields. Initial members include:

  • Dr. Mace Rothenberg, former CMO, Pfizer
  • Dr. Hesham Abdullah, Head of Oncology Global Clinical Development, GSK
  • Dr. Jerald Radich, Professor & Kurt Enslein Endowed Chair, Fred Hutchinson Cancer Research Center
  • Andrea Conners, Executive Director, Patient Empowerment Network
  • Phylicia L. Woods, Executive Director, Cancer Policy Institute, Cancer Support Community

Read more

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Read more